Tsvetelina Pencheva Hoang's most recent trade in Marker Therapeutics Inc was a trade of 33,159 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | Tsvetelina Pencheva Hoang | VP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 33,159 | 33,159 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Tsvetelina Pencheva Hoang | VP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Tsvetelina Pencheva Hoang | VP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |